Technical Analysis 101: Support and Resistance In this video I cover the basics of the support and resistance levels and how to chart it out, If you enjoyed this video please like it and share it with your friends. Also please drop a comment, feedback, suggestion for me to cover or just to work on, and that would be much appreciated. Next video I'll cover the Fibonacci retracement and extension to plot targets. So we covered the trend lines and support and resistance levels, so please practice with those and send me charts if you need someone to look over it! As the main goal is for all of us to learn from each other and become better chartist and traders!
Charting
$TNXPTonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, manufacturing, and licensing small molecules and biologics to treat and prevent human diseases and alleviate suffering. Its immunology product candidates include vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases; and central nervous system (CNS) product candidates comprise small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. The company's lead vaccine candidate is TNX-1800, a live replicating vaccine based on the horsepox viral vector platform to protect against COVID-19. Its vaccines also comprise TNX-801, a live horsepox virus vaccine to protect against smallpox and monkeypox and serves as the vector platform; and TNX-2300 and TNX-2600, which are live replicating attenuated vaccine candidates for the prevention of COVID-19. In addition, the company's lead CNS candidate is TNX-102 SL, a sublingual formulation of cyclobenzaprine, which is in Phase 3 development for fibromyalgia, as well as in Phase 2 studies for agitation in Alzheimer's disease and alcohol use disorder. Further, its products include TNX-1300, which is in Phase 2 development for the treatment of life-threatening cocaine intoxication; TNX-601 CR for depression; and TNX-1900 for migraine and cranio-facial pain treatment. Additionally, its preclinical pipeline includes TNX-1600 for posttraumatic stress disorder, depression, and attention deficit hyperactivity disorder; TNX-701 for radioprotection; TNX-1200, a smallpox vaccine; TNX-1500 for transplant organ rejection and autoimmune conditions; and TNX-1700 for gastric and pancreatic cancers. The company is headquartered in Chatham, New Jersey.
$VCNX PT 8 and higher (@snow6)Vaccinex, Inc., a clinical-stage biotechnology company, discovers and develops bio therapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab that is in clinical development stage for the treatment of non-small cell lung cancer (NSCLC), Huntington's disease, osteosarcoma, melanoma, and Alzheimer's disease. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and potentially for other autoimmune disorders; and VX25, a bi-specific natural killer T (NKT) cell stimulator, for the therapeutic application of NKT cell stimulation for cancer immunotherapy. It has a clinical trial collaboration and supply agreement with Merck KGaA to test pepinemab in combination with avelumab checkpoint inhibitor in NSCLC patients. Vaccinex, Inc. was founded in 2001 and is headquartered in Rochester, New York.
$BCRX PT 23 and higher (fm @Snake Doc)BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, ALPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma. It is also developing BCX7353, an oral serine protease inhibitor and oral dose formulation that is in Phase III clinical trials to treat hereditary angioedema; BCX9930, an oral factor D inhibitor, which is in Phase I clinical trials for mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors that is in Phase I clinical trials to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trials to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with U.S. Department of Health and Human Services; National Institute of Allergy and Infectious Diseases; Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
NZDJPY Short Scenario 1Here we see a chance for equal highs followed by a highly potential shorting opportunity. Great P/L Ratio!
Do you like my chartings? I’d love to hear about it! Please feel free to contact me here with any questions. I am always here to help!
And as always, May the force be with you!
ROADMAP-CHARTING 3DGuyzz & Dolzz,
Projecting a clear TA with fib channels "ROADMAP-CHARTING 3D".
This new style makes it easier to indicate price targets and placing ur sell and buy orders using the fib-channels.
Zooming in clearifies the importance of these lines.
Stocks, indices, commodities and FX
Combine this setup with your indicators and the price targets will become more clear.
Enjoy !
For questions and setup demands, leave me a message.
*** I do create "ROADMAP-CHARTING 3D" for Stocks, indices, commodities and FX only on request ! ***
Trade smart, trade safe,
Unicorn1
NzdJpy....still bullish until maybe....There might be possibility of a reversal pattern of h&s on this pair. But if it doesnt form, likely more upside for this pair!
#shadowingthebigboys
#trading
#forex
If you like my analysis and it helped you ,do give me a thumbs ups on tradingview! 🙏
And if you would like to show further support for me, you can gift me some coins on tradingview! 😁
Thank you!
Tradingview Disclaimer
Disclaimers:
The analysis shared through this channel are purely for educational and entertainment purposes only. They are by no means professional advice for individual/s to enter trades for investment or trading purposes.
The author/producer of these content shall not and will not be responsible for any form of financial/physical/assets losses incurred from trades executed from the derived conclusion of the individual from these content shared.
Thank you, and please do your due diligence before any putting on any trades!
$NNOX: Gap Fill Started, Needs to Break ResistanceCurrently it looks like Nanox on Friday have started to dramatically shift up, especially after hours with lots of the logarithmic curve that was downward already starting to curve. It still has lots of resistance given the rise of short sellers and puts, but that resistance seems to be fading. According to Algowins, when looking at short activity, the worst day in terms of test with over -49.6 was on September 15th, this was when a short seller released a report against Nanox. The "fear index" at that time was likely high. If Nanox increases in positive sentiment which looks to be the case, likely support levels can continue picking up for stable positive retest + stock growth. That said, please consider everything I say "as is", and on an opinion based basis. Do your own due diligence, and invest at your own risk.
1 Year Target for LI: $65Right now, my current 1 year target as a conservative estimate for Li Automotive is $65. That being said, I think this will continue getting momentum and garnishing higher support levels. Many analyst are bullish as well. As always, everything I say is on an opinion based basis. Please proceed with caution and invest at your own risk. Do your own due diligence.
Configuring Your Chart: HLC barsContrary to popular belief, the superior way to view price is not through candlesticks or OHLC bars.
Its HLC bars. HLC bars are the superior choice. Why? Good question...
The reason HLC bars are better is because I found out that the open price is completely redundant when analyzing the charts. Also the majority of indicators out there don't use the open price.
The open price is useless because it doesn't tell you what happened during the bar's life, only how it started, whereas the high, low, and close tell you how price moved during the hlc bar's life. The high, low, and closing prices of a bar are all you will ever need, and they tell you what the sentiment of the bar was. The equation for sentiment:
Sentiment = 100 * (Close - Low) / (High - Low)
What does this suggest? It suggests that candlestick patterns aren't real!
I used to believe in candlestick patterns. They were actually the first thing introduced to me when I started to learn about trading.
But now we all know the truth.
This is very good news because it simplifies the charts!
So next time you look at the charts, view them in HLC bars ;)
Decent Entry: USDCNHI believe that currently the USDCNH is having correlations previous to one of its last breakout patterns and that at the current price, it is a decent entry. I think currently this is mid risk. That being said, everything I say is on an opinion based basis. Please proceed with caution and do your own due diligence. Invest at your own risk.
ETH testing daily resistance! | 28th July 2020This is a chart shot of today's video on ETHUSD
Today we will take a good look at ETHUSD and what possible key levels to look out for. Right from the long term, down to the short term!
I utilise quite a bit of Fibonacci and graphical price action. Would be really lovely to hear your feedback and also have you guys share your views on the ETHUSD!
Let me know your thoughts and what other pairs you'd like me to take a look at next!
Cheers!
Entry:315.35
SL:336.23
TP:280.00
Chart TemplateSpent some time rethinking how I can markup the chart on multiple time frames. Avoiding Red and Green for bias, since old supply can become new demandn and vice versa. The goal was to minimize number of colors I need and relly on line style and weight. And utilizing higlight shades for key areas of interests.
I hope others can find this useful.
Take the Profits w/ ALT and ShortFirst off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. The bull run went too high in my opinion and the current wedge looks like it can receive some steep resistance. I think right now it is at a good level where it is a better idea to not try getting too greedy because just as it went up really high, it can also come crashing down steeply as well. Anyways, proceed with caution. If you like this, it is probably less risky to sell and than rebuy at the dip rather than hold long at this current level.
Divergent BarsDivergent bars help a trader identify a potential shift in the current price trend. Divergent bars are an effective technical tool for futures, options, and stock traders using any timeframe.
A divergent bar is defined as the following:
1. A potential shift from a bullish trend to a bearish trend is evidenced by the current price bar showing a higher high than the previous bar and the current bar closes in the bottom 50% of the price bar. Also known as a Bearish Divergent Bar . This indicates that bullish movement higher is weakening.
2. A potential shift from a bearish trend to a bullish trend is evidenced by the current price bar showing a lower low than the previous bar and the current bar closes in the upper 50% of the price bar. Also known as a Bullish Divergent Bar . This indicates that bearish movement lower is weakening.
To open a position using the divergent bar:
1. When the divergent bar indicates a possible bearish entry , place an order to buy to open a put (for options traders) or sell short (futures traders) at the low of the divergent bar. If the bullish trend is not complete, it is likely this position will not be filled. If, before the order is filled, the price moves above the high of the divergent bar, the bar is no longer valid as an entry signal and open orders should be cancelled. If the order is filled, use your usual profit targets, which will vary by trader. If the position is filled, futures traders should set a stop based on the high of the divergent bar. Options traders should monitor the price action and close the position if price moves above the high of the divergent bar.
2. When the divergent bar indicates a possible bullish entry , place an order to buy to open a call (for options traders) or buy long (futures traders) at the high of the divergent bar. If the bearish trend is not complete, it is likely this position will not be filled. If, before the order is filled, the price moves below the low of the divergent bar, the bar is no longer valid as an entry signal and open orders should be cancelled. If the order is filled, use your usual profit targets, which will vary by trader. If the position is filled, futures traders should set a stop based on the low of the divergent bar. Options traders should monitor the price action and close the position if price moves below the low of the divergent bar.
The most effective way to use the divergent bar signal is to view it as one signal aligned with another reliable signal, such as the Bollinger Bands, Awesome Oscillator, or other momentum/trend shift indicator. The signal is so specific that it adds exceptional strength to the likely reversal. For example, on the chart of TVC:SPX , two divergent bars are highlighted, each one anticipating a strong and clear reversal in the swing trend.
In the first example, a Bullish Divergent Bar appears at the beginning of October. The low is lower than the previous bar’s low and the current bar closes in the upper half of the price bar. This indicates a potential long entry. It is also paired with a Bollinger Band Snap. The next day stochastic crosses up and the high of the divergent bar is broken, signaling a long entry.
The second example occurs in late January with a Bearish Divergent Bar . The high of that bar is higher than the previous bar’s high and it also closes in the lower half of the price bar, signaling a bearish divergent bar. The next market day the low of the divergent bar is broken, the Awesome Oscillator (AO) is red, and stochastics is crossed down. This alignment between divergent bar, AO, and stochastics signals a short entry.
In both of these examples there is strong follow through from the divergent bar entry. Moving 35 points immediately to the upside on the bullish divergent bar entry and trending about 100 points lower the days following the bearish divergent bar entry. Divergent bars, when paired with other indicators, can be a reliable indication of a potential shift in the trend.